Serological Cross-Reactions between Expressed VP2 Proteins from Different Bluetongue Virus Serotypes
- PMID: 34452321
- PMCID: PMC8402635
- DOI: 10.3390/v13081455
Serological Cross-Reactions between Expressed VP2 Proteins from Different Bluetongue Virus Serotypes
Abstract
Bluetongue (BT) is a severe and economically important disease of ruminants that is widely distributed around the world, caused by the bluetongue virus (BTV). More than 28 different BTV serotypes have been identified in serum neutralisation tests (SNT), which, along with geographic variants (topotypes) within each serotype, reflect differences in BTV outer-capsid protein VP2. VP2 is the primary target for neutralising antibodies, although the basis for cross-reactions and serological variations between and within BTV serotypes is poorly understood. Recombinant BTV VP2 proteins (rVP2) were expressed in Nicotiana benthamiana, based on sequence data for isolates of thirteen BTV serotypes (primarily from Europe), including three 'novel' serotypes (BTV-25, -26 and -27) and alternative topotypes of four serotypes. Cross-reactions within and between these viruses were explored using rabbit anti-rVP2 sera and post BTV-infection sheep reference-antisera, in I-ELISA (with rVP2 target antigens) and SNT (with reference strains of BTV-1 to -24, -26 and -27). Strong reactions were generally detected with homologous rVP2 proteins or virus strains/serotypes. The sheep antisera were largely serotype-specific in SNT, but more cross-reactive by ELISA. Rabbit antisera were more cross-reactive in SNT, and showed widespread, high titre cross-reactions against homologous and heterologous rVP2 proteins in ELISA. Results were analysed and visualised by antigenic cartography, showing closer relationships in some, but not all cases, between VP2 topotypes within the same serotype, and between serotypes belonging to the same 'VP2 nucleotype'.
Keywords: BTV; Bluetongue virus; VP2; antigenic cartography; cross-serotype antibodies; orbivirus; orbivirus serotypes; plant expressed proteins.
Conflict of interest statement
G.P.L. declares that he is a named inventor on granted patent WO 29087391 A1 which describes the HyperTrans expression system and the pEAQ vectors used in this manuscript. The other authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures



References
-
- Mertens P.P., Diprose J., Maan S., Singh K.P., Attoui H., Samuel A.R. Bluetongue virus replication, molecular and structural biology. Vet. Ital. 2004;40:426–437. - PubMed
-
- Mertens P.P.C., Maan S., Samuel A., Attoui H. Orbivirus, Reoviridae. In: Fauquet M.A.M., Maniloff J., Desselberger U., Ball L.A., editors. Virus Taxonomy VIIIth Report of the ICTV. Elsevier; Amsterdam, The Netherlands: Academic Press; London, UK: 2004.
-
- More S., Bicout D., Bøtner A., Butterworth A., Depner K., Edwards S., Garin-Bastuji B., Good M., Gortazar-Schmidt C., Michel V., et al. Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): Bluetongue. EFSA J. 2017;15:4957. - PubMed